Protein kinase A phosphorylates Down syndrome critical region 1 (RCAN1)

Seon Sook Kim, Yohan Oh, Kwang Chul Chung, Su Ryeon Seo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The Down syndrome critical region 1 (DSCR1) gene encodes a regulator of the calcineurin 1 (RCAN1) protein, and the elevated levels of RCAN1 are associated with Alzheimer's disease (AD) and Down syndrome (DS). In this report, we found that protein kinase A (PKA) was able to phosphorylate RCAN1 in vitro and in vivo. In addition, we found that the phosphorylation of RCAN1 by PKA caused an increase of RCAN1 expression by increasing of the half-life of the protein. Consistently, the pharmacological inhibition of intracellular PKA using H-89 and the knockdown of the endogenous PKA catalytic subunit with siRNA decreased the expression of RCAN1. Furthermore, the phosphorylation of RCAN1 by PKA enhanced the inhibitory function of RCAN1 on calcineurin-mediated gene transcription. Our data provide the first evidence that PKA acts as an important regulatory component in the control of RCAN1 function through phosphorylation.

Original languageEnglish
Pages (from-to)657-661
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume418
Issue number4
DOIs
Publication statusPublished - 2012 Feb 24

Fingerprint

Calcineurin
Cyclic AMP-Dependent Protein Kinases
Phosphorylation
Alzheimer Disease
Genes
Down Syndrome Critical Region
Transcription
Down Syndrome
Small Interfering RNA
Half-Life
Catalytic Domain
Proteins
Pharmacology

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

@article{788278ddd4234f61a25b5e750f1372a5,
title = "Protein kinase A phosphorylates Down syndrome critical region 1 (RCAN1)",
abstract = "The Down syndrome critical region 1 (DSCR1) gene encodes a regulator of the calcineurin 1 (RCAN1) protein, and the elevated levels of RCAN1 are associated with Alzheimer's disease (AD) and Down syndrome (DS). In this report, we found that protein kinase A (PKA) was able to phosphorylate RCAN1 in vitro and in vivo. In addition, we found that the phosphorylation of RCAN1 by PKA caused an increase of RCAN1 expression by increasing of the half-life of the protein. Consistently, the pharmacological inhibition of intracellular PKA using H-89 and the knockdown of the endogenous PKA catalytic subunit with siRNA decreased the expression of RCAN1. Furthermore, the phosphorylation of RCAN1 by PKA enhanced the inhibitory function of RCAN1 on calcineurin-mediated gene transcription. Our data provide the first evidence that PKA acts as an important regulatory component in the control of RCAN1 function through phosphorylation.",
author = "Kim, {Seon Sook} and Yohan Oh and Chung, {Kwang Chul} and Seo, {Su Ryeon}",
year = "2012",
month = "2",
day = "24",
doi = "10.1016/j.bbrc.2012.01.071",
language = "English",
volume = "418",
pages = "657--661",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

Protein kinase A phosphorylates Down syndrome critical region 1 (RCAN1). / Kim, Seon Sook; Oh, Yohan; Chung, Kwang Chul; Seo, Su Ryeon.

In: Biochemical and Biophysical Research Communications, Vol. 418, No. 4, 24.02.2012, p. 657-661.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Protein kinase A phosphorylates Down syndrome critical region 1 (RCAN1)

AU - Kim, Seon Sook

AU - Oh, Yohan

AU - Chung, Kwang Chul

AU - Seo, Su Ryeon

PY - 2012/2/24

Y1 - 2012/2/24

N2 - The Down syndrome critical region 1 (DSCR1) gene encodes a regulator of the calcineurin 1 (RCAN1) protein, and the elevated levels of RCAN1 are associated with Alzheimer's disease (AD) and Down syndrome (DS). In this report, we found that protein kinase A (PKA) was able to phosphorylate RCAN1 in vitro and in vivo. In addition, we found that the phosphorylation of RCAN1 by PKA caused an increase of RCAN1 expression by increasing of the half-life of the protein. Consistently, the pharmacological inhibition of intracellular PKA using H-89 and the knockdown of the endogenous PKA catalytic subunit with siRNA decreased the expression of RCAN1. Furthermore, the phosphorylation of RCAN1 by PKA enhanced the inhibitory function of RCAN1 on calcineurin-mediated gene transcription. Our data provide the first evidence that PKA acts as an important regulatory component in the control of RCAN1 function through phosphorylation.

AB - The Down syndrome critical region 1 (DSCR1) gene encodes a regulator of the calcineurin 1 (RCAN1) protein, and the elevated levels of RCAN1 are associated with Alzheimer's disease (AD) and Down syndrome (DS). In this report, we found that protein kinase A (PKA) was able to phosphorylate RCAN1 in vitro and in vivo. In addition, we found that the phosphorylation of RCAN1 by PKA caused an increase of RCAN1 expression by increasing of the half-life of the protein. Consistently, the pharmacological inhibition of intracellular PKA using H-89 and the knockdown of the endogenous PKA catalytic subunit with siRNA decreased the expression of RCAN1. Furthermore, the phosphorylation of RCAN1 by PKA enhanced the inhibitory function of RCAN1 on calcineurin-mediated gene transcription. Our data provide the first evidence that PKA acts as an important regulatory component in the control of RCAN1 function through phosphorylation.

UR - http://www.scopus.com/inward/record.url?scp=84862820897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862820897&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2012.01.071

DO - 10.1016/j.bbrc.2012.01.071

M3 - Article

VL - 418

SP - 657

EP - 661

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -